by Michelle Stewart, PhD; Adam Butler; Larry Alphs, MD, PhD; Phillip B. Chappell, MD; Douglas E. Feltner, MD; William R. Lenderking, PhD; Atul R. Mahableshwarkar, MD; Clare W. Makumi, PharmD,
by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland.
Dear Colleagues: Welcome to the April issue of Innovations in Clinical Neuroscience. This month, we lead with a topic we are covering for the first time in the journal and
by Suzanne C. Perkins, Eric D. Finegood, and James E. Swain Dr. Perkins is from Department of Psychiatry, Faculty of Medicine, University of Michigan, Ann Arbor, Michigan; Mr. Finegood is
by Fatemeh Naddafi, MSc; Mohsen Reza Haidari, PhD; Gholamreza Azizi, MSc; Reza Sedaghat, PhD; and Abbas Mirshafiey, PhD Ms. Naddafi is from Department of Cellular and Molecular Biology, Kish International
by Kenneth Osiezagha, MD; Shahid Ali, MD; C. Freeman, MD; Narviar C. Barker, PhD; Shagufta Jabeen, MD; Sarbani Maitra, MD; Yetunde Olagbemiro, MD; William Richie, MD, FAPA; and Rahn K.